Star Combo Pharma Limited 2026 Appendix 4E Preliminary Final Report ASX: S66 Star Combo Pharma Limited 2026 Preliminary Final Report Page 1 STAR COMBO PHARMA LTD AND CONTROLLED ENTITIES ABN 38 615 728 375 APPENDIX 4E PRELIMINARY FINAL REPORT FOR THE YEAR...
S66 Preliminary Final Report & Full Year Statutory Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Star Combo Pharma
- S66 Dec 25 Half Year Report and Financial Statements
- S66 FYE June 2025 Results Announcement
- S66 Preliminary Final Report
- S66 Insurance Claim Settlement
- S66 Dec 2024 Half Year Report & Financial Statements
Later from Star Combo Pharma
- Dividend/Distribution - S66
- S66 Date of 2026 AGM
- S66 2026 Annual Report
- S66 2026 AGM - NOM / EM / Proxy
- S66 2026 Corporate Governance Statement
Follow Star Combo Pharma into a list and get an email when it puts out news.
Follow Star Combo Pharma